Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate Update
Go back to Ultragenyx Reports Second Quarter 2019 Financial Results and Corporate Update| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 28.95 -0.08 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $29.03 | 52 Week High | $117.12 | |||
| Open | $28.58 | 52 Week Low | $46.52 | |||
| Day High | $29.39 | P/E | N/A | |||
| Day Low | $28.50 | EPS | $-1.97 | |||
| Volume | 1,131,791 | |||||
